Parataxis Holdings will go public and acquire South Korea’s Bridge Biotherapeutics, rebranding it as Parataxis Korea to establish a direct presence in the Korean market. The company plans to build a US$640 million Bitcoin treasury, positioning itself as a major institutional BTC holder targeting both US and Korean investors. TrumpContinue Reading